✦ LIBER ✦

A RANDOMIZED COMPARISON OF THE ENDEAVOR DRUG (ABT-578) ELUTING STENT VERSUS TAXUS PACLITAXEL-ELUTING STENT IN DIABETIC PATIENTS: THREE-YEAR OUTCOMES FROM ENDEAVOR IV

✍ Scribed by Kirtane, Ajay; Patel, Rikesh; O'Shaunessy, Charles; McLaurin, Brent; Kandzari, David E.; Leon, Martin B.

Book ID: 123337607
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 101 KB
Volume: 55
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(10)61981-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized Comparison of the Endeavor

A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions: 12-Month Outcomes From the ENDEAVOR IV Trial

✍ Martin B. Leon; Laura Mauri; Jeffrey J. Popma; Donald E. Cutlip; Eugenia Nikolsk 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 923 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

Comparison of three-year clinical outcom

Comparison of three-year clinical outcomes between sirolimus-versus paclitaxel-eluting stents in diabetic patients: Prospective randomized multicenter trial

✍ Soon Jun Hong; Moo Hyun Kim; Kwang Soo Cha; Hun Sik Park; Shung Chull Chae; Seun 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB 👁 2 views

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB

FIVE YEAR CLINICAL RESULTS FROM ENDEAVOR

FIVE YEAR CLINICAL RESULTS FROM ENDEAVOR III: A RANDOMIZED COMPARISON OF THE ZOTAROLIMUS-ELUTING VERSUS SIROLIMUS-ELUTING STENTS IN DE NOVO NATIVE CORONARY LESIONS

✍ Kandzari, David E.; Mauri, Laura; Popma, Jeffrey; Turco, Mark A.; O'Shaunessy, C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 73 KB

TCT-404: Late Safety and Efficacy of a Z

TCT-404: Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB